Facebook
Twitter
Telegram
Report an ErrorCyclerion Therapeutics Cash Flow 2011-2024 | CYCN
Annual Cash Flow Cyclerion Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-21.2 M | -40.6 M | -36.5 M | -72.5 M | -102 M | -97.5 M | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | 65 K | 472 K | 2.3 M | 2.7 M | 1.53 M | - | - | - | - | - | - | - |
Accounts Payables |
1.2 M | 2.97 M | 1.83 M | 1.15 M | 3.23 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | 96 K | 100 K | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Cyclerion Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.87 M | - | - | - | -6.21 M | - | -33.6 M | -23.7 M | -12.8 M | - | -27.9 M | -20 M | -14.5 M | - | -58.4 M | -43.4 M | -29.2 M | - | -80.1 M | -56.2 M | -34.3 M | - | -74.4 M | -49 M | -26.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | 65 K | 65 K | 48 K | - | 424 K | 376 K | 258 K | - | 600 K | 600 K | 626 K | - | 700 K | 800 K | 525 K | - | 400 K | 400 K | 356 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
741 K | 1.2 M | 814 K | 1.86 M | - | 2.97 M | 1.64 M | 2.77 M | 2.52 M | 1.83 M | 1.17 M | 1.39 M | 1.1 M | 1.15 M | 1.15 M | 1.15 M | 1.15 M | 3.23 M | 3.23 M | 3.23 M | 3.23 M | 2.78 M | 2.78 M | 2.78 M | 2.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | 96 K | 227 K | 227 K | 227 K | 100 K | 158 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency